TXG

10x Genomics, Inc. Class A Common Stock

76.54

USD

-0.43

-0.56%

Sep 18, 12:09 UTC -4

Open

10x Genomics, Inc. Class A Common Stock Profile

About

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

Info & Links

CEO

Serge Saxonov

Headquarters

6230 STONERIDGE MALL ROAD
PLEASANTON, CA 94588, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

473

10x Genomics, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

9.97B

Enterprise Value

9.47B

Enterprise Value/EBITDA(ttm)

-234.14

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

15.35

Price to Book(mrq)

11.47

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

70.07%

Operating Margin(ttm)

-12.18%

Profit Margin(ttm)

-12.26%

Return on Equity(ttm)

-9.33%

Return on Invested Capital(ttm)

-9.37%

Return on Assets(ttm)

-7.30%

Income Statement

Revenue(ttm)

616.91M

Revenue Per Share(ttm)

4.73

Gross Profit(ttm)

432.03M

EBITDA(ttm)³

-40.44M

Net Income Available to Common(ttm)

-75.13M

Diluted EPS(ttm)

-0.59

Share Statistics

Beta (5Y Monthly)

2.08

52-Week Change

495.15%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

130.29M

Dividend Yield

0.00%

Float⁴

118.77M

% Held by Insiders

8.84%

% Held by Institutions

84.68%

Balance Sheet

Total Cash(mrq)

552.03M

Total Cash Per Share(mrq)

4.24

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.69%

Quick Ratio(mrq)

5.25%

Book Value Per Share(mrq)

6.34

Cash Flow

Operating Cash Flow Per Share(ytd)

0.33

Free Cash Flow(ytd)

39.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TXG